Black Diamond Therapeutics Presents Novel Real-World : compa

Real-world data demonstrate non-classical mutations are present in 20-30% of all patients with EGFRm NSCLC Emerging data show non-classical EGFR mutations...

Related Keywords

California , United States , San Diego , Cambridge , Cambridgeshire , United Kingdom , American , Mario Corso , Xiuning Le , John Heymach , Guardant Health , Nasdaq , Md Anderson Cancer Center , American Association Of Cancer Research , Foundation Medicine Foundationinsights , Diamond Therapeutics Inc , Exchange Commission , Company Masterkey , Diamond Therapeutics , Cancer Research , Annual Meeting , Targeting Classical , Resistance Mutation , Evolved Landscape , Foundation Medicine , Neck Medical Oncology , Associate Professor , Elizabeth Buck , Chief Scientific Officer , Black Diamond , Private Securities Litigation Reform Act , Annual Report , United States Securities , Investor Relations , Nasdaq Bdtx , Black Diamond Therapeutics , Nc ,